Localized Castleman’s disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal

By Androulaki A.   Giaslakiotis K.   Giakoumi X.   Aessopos A.   Lazaris A.  

Annals of Hematology, Vol. 86, Iss. 1, 2007-01 ,pp. : 55-57

Springer Publishing Company

Access to resources Recommend Favorite

Apolipoprotein E and Apolipoprotein A-1 Knock-Out Mice Readily Develop Amyloid A Protein Amyloidosis

By Elliott-Bryant R.   Cathcart E.S.  

Clinical Immunology, Vol. 85, Iss. 1, 1997-10 ,pp. : 104-108

Academic Press

Access to resources Recommend Favorite

Infectivity of amyloid diseases

By Sigurdsson E.M.   Wisniewski T.   Frangione B.  

Trends in Molecular Medicine, Vol. 8, Iss. 9, 2002-09 ,pp. : 411-413

Elsevier

Access to resources Recommend Favorite

Antisense peptides designed to inhibit -amyloid aggregation

By Cuccia L.  

Trends in Molecular Medicine, Vol. 8, Iss. 5, 2002-05 ,pp. : 202-202

Elsevier

Access to resources Recommend Favorite

Examination of serum amyloid a protein in kidney transplant patients

By Fukuda Y.   Hoshino S.   Tanaka I.   Yoneya T.   Takeshita T.   Sumimoto R.   Kanbe M.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1796-1798

Elsevier

Access to resources Recommend Favorite